268 related articles for article (PubMed ID: 33670447)
1. Serum Long Non-Coding RNAs PVT1, HOTAIR, and NEAT1 as Potential Biomarkers in Egyptian Women with Breast Cancer.
El-Fattah AAA; Sadik NAH; Shaker OG; Mohamed Kamal A; Shahin NN
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33670447
[TBL] [Abstract][Full Text] [Related]
2. [Long non-coding RNA HOTAIR in plasma as a potential biomarker for breast cancer diagnosis].
Zhang KJ; Zhang Y; Luo ZL; Liu L; Yang J; Wu LC; Yu SS; Liu JB
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 36(4):488-92. PubMed ID: 27113175
[TBL] [Abstract][Full Text] [Related]
3. Circulating DNA of HOTAIR in serum is a novel biomarker for breast cancer.
Zhang L; Song X; Wang X; Xie Y; Wang Z; Xu Y; You X; Liang Z; Cao H
Breast Cancer Res Treat; 2015 Jul; 152(1):199-208. PubMed ID: 26033707
[TBL] [Abstract][Full Text] [Related]
4. Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian women.
Motawi TM; Sadik NA; Shaker OG; El Masry MR; Mohareb F
Gene; 2016 Sep; 590(2):210-9. PubMed ID: 26827795
[TBL] [Abstract][Full Text] [Related]
5. Salivary HOTAIR and PVT1 as novel biomarkers for early pancreatic cancer.
Xie Z; Chen X; Li J; Guo Y; Li H; Pan X; Jiang J; Liu H; Wu B
Oncotarget; 2016 May; 7(18):25408-19. PubMed ID: 27028998
[TBL] [Abstract][Full Text] [Related]
6. Association analyses of a genetic variant in long non-coding RNA MEG3 with breast cancer susceptibility and serum MEG3 expression level in the Egyptian population.
Ali MA; Shaker OG; Alazrak M; AbdelHafez MN; Khalefa AA; Hemeda NF; Abdelmoktader A; Ahmed FA
Cancer Biomark; 2020; 28(1):49-63. PubMed ID: 32176630
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNAs as novel prognostic biomarkers for breast cancer in Egyptian women.
El-Helkan B; Emam M; Mohanad M; Fathy S; Zekri AR; Ahmed OS
Sci Rep; 2022 Nov; 12(1):19498. PubMed ID: 36376369
[TBL] [Abstract][Full Text] [Related]
8. Unleash multifunctional role of long noncoding RNAs biomarker panel in breast cancer: a predictor classification model.
Toraih EA; El-Wazir A; Ageeli EA; Hussein MH; Eltoukhy MM; Killackey MT; Kandil E; Fawzy MS
Epigenomics; 2020 Jul; 12(14):1215-1237. PubMed ID: 32812439
[No Abstract] [Full Text] [Related]
9. Diagnostic and prognostic role of serum miR-20b, miR-17-3p, HOTAIR, and MALAT1 in diabetic retinopathy.
Shaker OG; Abdelaleem OO; Mahmoud RH; Abdelghaffar NK; Ahmed TI; Said OM; Zaki OM
IUBMB Life; 2019 Mar; 71(3):310-320. PubMed ID: 30468285
[TBL] [Abstract][Full Text] [Related]
10. Interplay of lncRNA H19/miR-675 and lncRNA NEAT1/miR-204 in breast cancer.
Müller V; Oliveira-Ferrer L; Steinbach B; Pantel K; Schwarzenbach H
Mol Oncol; 2019 May; 13(5):1137-1149. PubMed ID: 30803129
[TBL] [Abstract][Full Text] [Related]
11. Circulating long non-coding HOX transcript antisense intergenic ribonucleic acid in plasma as a potential biomarker for diagnosis of breast cancer.
Zhang Y; Zhang K; Luo Z; Liu L; Wu L; Liu J
Thorac Cancer; 2016 Nov; 7(6):627-632. PubMed ID: 27755794
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of PVT1 and NEAT1 lncRNAs in pituitary adenomas.
Ghafouri-Fard S; Abbasi F; Nicknam A; Hussen BM; Eslami S; Akbari Dilmaghani N; Taheri M; Sharifi G
Pathol Res Pract; 2023 Aug; 248():154573. PubMed ID: 37270938
[TBL] [Abstract][Full Text] [Related]
13. Circulating HOTAIR expression predicts the clinical response to neoadjuvant chemotherapy in patients with breast cancer.
Lu R; Zhang J; Zhang W; Huang Y; Wang N; Zhang Q; Qu S
Cancer Biomark; 2018; 22(2):249-256. PubMed ID: 29630518
[TBL] [Abstract][Full Text] [Related]
14. Circulating long non-coding RNA MALAT1 expression as molecular biomarker in Egyptian patients with breast cancer.
Zidan HE; Karam RA; El-Seifi OS; Abd Elrahman TM
Cancer Genet; 2018 Jan; 220():32-37. PubMed ID: 29310836
[TBL] [Abstract][Full Text] [Related]
15. Impact of breast cancer surgery on angiogenesis circulating biomarkers: a prospective longitudinal study.
Georgiou GK; Igglezou M; Sainis I; Vareli K; Batsis H; Briasoulis E; Fatouros M
World J Surg Oncol; 2013 Aug; 11():213. PubMed ID: 23981902
[TBL] [Abstract][Full Text] [Related]
16. Plasma long non-coding RNAs (lncRNAs) serve as potential biomarkers for predicting breast cancer.
Jiao ZY; Tian Q; Li N; Wang HB; Li KZ
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1994-1999. PubMed ID: 29687854
[TBL] [Abstract][Full Text] [Related]
17. Gene Expression of the Circulating Long Noncoding RNA
Ismail DM; Shaker OG; Kandeil MA; Hussein RM
Genet Test Mol Biomarkers; 2019 Sep; 23(9):671-680. PubMed ID: 31433231
[No Abstract] [Full Text] [Related]
18. Clinical impact of LncRNA XIST and LncRNA NEAT1 for diagnosis of high-risk group breast cancer patients.
Swellam M; El Magdoub HM; Shawki MA; Adel M; Hefny MM; El-Shazly SS
Curr Probl Cancer; 2021 Oct; 45(5):100709. PubMed ID: 33602501
[TBL] [Abstract][Full Text] [Related]
19. Combined identification of long non-coding RNA CCAT1 and HOTAIR in serum as an effective screening for colorectal carcinoma.
Zhao W; Song M; Zhang J; Kuerban M; Wang H
Int J Clin Exp Pathol; 2015; 8(11):14131-40. PubMed ID: 26823726
[TBL] [Abstract][Full Text] [Related]
20. LncRNAs
Ali MA; Shaker OG; Khalifa AA; Ezzat EM; Elghobary HA; Abdel Mawla TS; Elkhateeb AF; Elebiary AMA; Elamir AM
Noncoding RNA Res; 2023 Mar; 8(1):96-108. PubMed ID: 36439973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
